ABBOTT PARK, Ill., June 14, 2011 /PRNewswire/ -- Abbott (NYSE: ABT) announced today that the U.S. Food and Drug Administration (FDA) has approved an infant-specific dose of CREON® (pancrelipase) ...

WASHINGTON, May 1 (Reuters) - U.S. health officials have formally approved Solvay SA's enzyme drug Creon for adults and children with a digestive disorder resulting from conditions such as cystic ...

Abbott Laboratories ABT obtained U.S. Food and Drug Administration approval for an infant-specific dose of Creon, its pancreatic enzyme replacement therapy. Most people with cystic fibrosis suffer ...

(Recasts first paragraph, adds virus details, Creon revenues) By Susan Heavey WASHINGTON, Nov 28 (Reuters) - U.S. health regulators are concerned about the risk of patients contracting viruses from ...

Creon is a brand-name prescription medication that can treat exocrine pancreatic insufficiency (EPI). The cost of Creon through Medicare may vary depending on many factors, such as a person’s ...

The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. CREON MICRO contains the active ingredient Pancreatic Extract. CREON ...

Creon is a medication used to treat exocrine pancreatic insufficiency (EPI), a condition in which your pancreas doesn’t produce enough enzymes for you to digest your foods. Medicare covers Creon, but ...

Assistant Professor, Eastern Virginia Medical School, Norfolk, Virginia; Clinical Pharmacist, Chesapeake Regional Medical Center, Chesapeake, Virginia More than a dozen pancreatic enzyme drug products ...